NDC 0832-6023

Carbamazepin

Carbamazepine

Carbamazepin is a Oral Tablet, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Upsher-smith Laboratories, Llc. The primary component is Carbamazepine.

Product ID0832-6023_aadc79a0-f144-46e3-b324-17dbc422f5a1
NDC0832-6023
Product TypeHuman Prescription Drug
Proprietary NameCarbamazepin
Generic NameCarbamazepine
Dosage FormTablet, Extended Release
Route of AdministrationORAL
Marketing Start Date2021-04-13
Marketing CategoryANDA /
Application NumberANDA213311
Labeler NameUpsher-Smith Laboratories, LLC
Substance NameCARBAMAZEPINE
Active Ingredient Strength200 mg/1
Pharm ClassesDecreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC],Cytochrome P450 3A4 Inducers [MoA],Cytochrome P450 1A2 Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 2C19 Inducers [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 0832-6023-11

100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0832-6023-11)
Marketing Start Date2021-04-13
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Carbamazepin" or generic name "Carbamazepine"

NDCBrand NameGeneric Name
0093-0109CarbamazepineCarbamazepine
0093-0778CarbamazepineCarbamazepine
0093-0090EpitolCarbamazepine
0078-0508Tegretolcarbamazepine
0078-0509Tegretolcarbamazepine
0078-0510Tegretolcarbamazepine
0078-0511Tegretolcarbamazepine
0078-0512Tegretolcarbamazepine

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.